The Patented Medicine Prices Review aboard (PMPRB) has extended the deadline for written submissions on new Draft Guidelines until January 31, 2020. Originally, the consultation was scheduled to run until January 20, 2020.

Background

As we reported, the Board proposed Draft Guidelines to replace its existing price-review practices, including the Compendium of Policies, Guidelines and Procedures. The changes are intended to implement the recent amendments to the Patented Medicines Regulations, which come into force on July 1, 2020. The PMPRB released the Draft Guidelines on November 21, 2019.

Consultation update

According to a December 10, 2019 update on its consultation website, the PMPRB has been meeting with stakeholders. These meetings have included a one-day outreach session with industry on compliance and operational issues on December 9, 2019, and a “civil society” forum on December 10, 2019, both in Ottawa. The PMPRB also stated that its outreach efforts in this consultation include “the possibility for individual companies to request bilateral meetings with the PMPRB at any time during the consultation period”.